A Phase I/IIa, Multicenter, Open-label, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration.
- Year: 2013
- Type: Pharmaceutical - Pain
- Phase: I, IIa
- Indication: Back and/or Leg Pain